![Efficacy and safety of BT595 (10% human intravenous immunoglobulin) in adult patients with chronic immune thrombocytopenia - Demeter - Transfusion Medicine - Wiley Online Library Efficacy and safety of BT595 (10% human intravenous immunoglobulin) in adult patients with chronic immune thrombocytopenia - Demeter - Transfusion Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/88339992-4e5d-41bc-b136-576fd889df55/tme12943-fig-0001-m.jpg)
Efficacy and safety of BT595 (10% human intravenous immunoglobulin) in adult patients with chronic immune thrombocytopenia - Demeter - Transfusion Medicine - Wiley Online Library
The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple
![BT595, a 10% Human Normal Immunoglobulin, for Replacement Therapy of Primary Immunodeficiency Disease: Results of a Subcohort Analysis in Children | SpringerLink BT595, a 10% Human Normal Immunoglobulin, for Replacement Therapy of Primary Immunodeficiency Disease: Results of a Subcohort Analysis in Children | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10875-022-01397-0/MediaObjects/10875_2022_1397_Fig1_HTML.png)
BT595, a 10% Human Normal Immunoglobulin, for Replacement Therapy of Primary Immunodeficiency Disease: Results of a Subcohort Analysis in Children | SpringerLink
![CD24 mediates rolling of breast carcinoma cells on P‐selectin - Aigner - 1998 - The FASEB Journal - Wiley Online Library CD24 mediates rolling of breast carcinoma cells on P‐selectin - Aigner - 1998 - The FASEB Journal - Wiley Online Library](https://faseb.onlinelibrary.wiley.com/cms/asset/3ca40b60-f7a4-444e-b345-099c6d5bb986/fsb2fasebj12121241-fig-0008-m.jpg)